Literature DB >> 21240862

High prevalence of pseudoexfoliation syndrome and its complications in Tarragona in northeast Spain.

Pedro Romero-Aroca1, Robert Masip-Serra, Inmaculada Martínez-Salcedo, Merce Salvat-Serra, Joan Fernández-Ballart, Angel Bautista-Pérez.   

Abstract

PURPOSE: To determine the prevalence of pseudoexfoliation syndrome (PEX) in our health area, in 4 counties of Tarragona, and its involvement in the health status of the population.
METHODS: This was a cross-sectional study of a sample of 2,342 inhabitants aged = 60 years, randomly selected from the population census. Subjects were classified in 3 groups according to age (group 1 = 60-69 years, group 2 = 70-79 years, group 3 = over 80 years). The diagnosis of PEX was made in all cases by the same ophthalmologist, using biomicroscopic and slit-lamp evaluation. Corneal endothelial study was made by specular microscope.
RESULTS: The prevalence of PEX was 309/2,342 patients (13.19%), unilateral in 219/309 (70.87%). The prevalence of PEX in patients with open-angle glaucoma was 29.48%. Changes in corneal endothelium were higher in patients with PEX, with lower cell density and hexagonality percentage, with higher coefficient of variation, significant in age groups 2 and 3. The prevalence of cataract in patients with PEX was 80.58%, versus 54.64% in patients without PEX. Complications of cataract surgery were higher in patients with PEX and postoperative corneal edema was best correlated with a low hexagonality percentage. No systemic cardiovascular diseases were significant in patients with PEX.
CONCLUSIONS: In our health district area, a high prevalence of PEX exists. A more extensive study of the causes of these differences is needed, including analysis of the genetic makeup of the population.

Entities:  

Mesh:

Year:  2011        PMID: 21240862     DOI: 10.5301/EJO.2011.6254

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  8 in total

1.  Prevalence of pseudoexfoliation syndrome and its association with ocular and systemic diseases in Eskisehir, Turkey.

Authors:  Nilgun Yildirim; Erdogan Yasar; Huseyin Gursoy; Ertugrul Colak
Journal:  Int J Ophthalmol       Date:  2017-01-18       Impact factor: 1.779

Review 2.  Corneal Alterations Associated with Pseudoexfoliation Syndrome and Glaucoma: A Literature Review.

Authors:  Joel R Palko; Owen Qi; Arsham Sheybani
Journal:  J Ophthalmic Vis Res       Date:  2017 Jul-Sep

3.  The Melaka Hospital cataract complications study analysis of 12,992 eyes.

Authors:  Thanigasalam Thevi; Zin Maizura; Adinegara Lutfi Abas
Journal:  Indian J Ophthalmol       Date:  2017-01       Impact factor: 1.848

4.  Exfoliation Syndrome in Egypt: Prevalence and Association with Cataract in a Large Cohort.

Authors:  Bassem Fayez Aziz; Amr Ismail Elawamry; Maged Maher Roshdy; Caroline Atef Tawfik
Journal:  Ophthalmol Ther       Date:  2021-09-27

5.  Exfoliation Syndrome in Baja Verapaz Guatemala: A Cross-Sectional Study and Review of the Literature.

Authors:  Chase Paulson; Samuel C Thomas; Orlando Gonzalez; Samuel Taylor; Cole Swiston; Jennifer S Herrick; Lori McCoy; Karen Curtin; Craig J Chaya; Brian C Stagg; Barbara M Wirostko
Journal:  J Clin Med       Date:  2022-03-24       Impact factor: 4.241

6.  Comparison of Cardiovascular Risk and Events among Spanish Patients with and without Ocular Pseudoexfoliation.

Authors:  Nora Imaz Aristimuño; Iñaki Rodriguez Agirretxe; Ricardo San Vicente Blanco; Rafael Rotaeche Del Campo; Javier Mendicute Del Barrio
Journal:  J Clin Med       Date:  2022-04-12       Impact factor: 4.964

Review 7.  A Case-Cohort Study of Exfoliation Risk Factors and Literature Review.

Authors:  Ahmad M Mansour; Anastasios G P Konstas; Hana A Mansour; Abdul R Charbaji; Khalil M El Jawhari
Journal:  Middle East Afr J Ophthalmol       Date:  2021-04-30

8.  Prevalence of Open-angle Glaucoma in the Faroese Population.

Authors:  Elin Holm; Malan Holm; Kaj Vilhelmsen; Gudrid Andorsdottir; Henrik Vorum; Allie Simpson; Benjamin R Roos; John H Fingert; Thomas Rosenberg
Journal:  J Glaucoma       Date:  2022-02-01       Impact factor: 2.290

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.